BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33747079)

  • 1. A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma.
    Xu H; Zou R; Liu J; Zhu L
    J Oncol; 2021; 2021():6653247. PubMed ID: 33747079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Guo F; Hong J
    Front Genet; 2020; 11():441. PubMed ID: 32431729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
    Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
    Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Prediction Using a Stemness Index-Related Signature in a Cohort of Gastric Cancer.
    Chen X; Zhang D; Jiang F; Shen Y; Li X; Hu X; Wei P; Shen X
    Front Mol Biosci; 2020; 7():570702. PubMed ID: 33134315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
    Zheng J; Zhang YW; Pan ZF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma.
    Zhang H; Cao C; Xiong H
    Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
    Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C
    Front Oncol; 2021; 11():626961. PubMed ID: 33747944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
    Chen M; Wang X; Wang W; Gui X; Li Z
    Front Immunol; 2022; 13():829057. PubMed ID: 35833114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
    Zhao X; Lin J
    Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma.
    Hou S; Xu H; Liu S; Yang B; Li L; Zhao H; Jiang C
    Front Genet; 2022; 13():860268. PubMed ID: 35464867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.
    Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N
    Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823
    [No Abstract]   [Full Text] [Related]  

  • 13. A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma.
    Huang XY; Qin WT; Su QS; Qiu CC; Liu RC; Xie SS; Hu Y; Zhu SY
    Biomed Res Int; 2021; 2021():6669570. PubMed ID: 34671679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative Analysis of Biomarkers Through Machine Learning Identifies Stemness Features in Colorectal Cancer.
    Wei R; Quan J; Li S; Liu H; Guan X; Jiang Z; Wang X
    Front Cell Dev Biol; 2021; 9():724860. PubMed ID: 34568334
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of stemness index-related long noncoding RNA SNHG12 in human bladder cancer based on WGCNA.
    Zhang B; He Y; Ma G; Zhang L; Qi P; Han D; Yue Z; Shang P
    Mol Cell Probes; 2022 Dec; 66():101867. PubMed ID: 36183925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma.
    Li Z; Jin C; Lu X; Zhang Y; Zhang Y; Wen J; Liu Y; Liu X; Li J
    Ann Transl Med; 2023 Jan; 11(2):61. PubMed ID: 36819514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma.
    Wang W; Xu C; Ren Y; Wang S; Liao C; Fu X; Hu H
    Stem Cells Int; 2021; 2021():7036059. PubMed ID: 34691191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene-related signature associated with prognosis and therapy response.
    Chen L; Zhang D; Zheng S; Li X; Gao P
    Front Genet; 2022; 13():959834. PubMed ID: 36110210
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.
    Kang Y; Zhu X; Wang X; Liao S; Jin M; Zhang L; Wu X; Zhao T; Zhang J; Lv J; Zhu D
    Front Oncol; 2021; 11():641184. PubMed ID: 33816287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.
    Pei J; Wang Y; Li Y
    J Transl Med; 2020 Feb; 18(1):74. PubMed ID: 32050983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.